Hannover Medical School

This study tests the safety of empagliflozin, a diabetes medicine, in 44 adults with fast-growing polycystic kidney disease. Some participants also take another drug called tolvaptan. Researchers will measure changes in kidney size and function over 18 months to see if the drug h…

This study looks at whether the antiviral drug Bulevirtide can reduce high blood pressure in the liver (portal hypertension) in people with hepatitis B and D who also have liver cirrhosis. High liver pressure can lead to serious problems like bleeding. The study will measure live…

This study looks at whether a large-scale lung cancer screening program can be set up in Germany. It involves 12,100 current or former smokers aged 55-79. The goal is to see which method (NELSON or PLCO) works best for finding lung cancer early, so treatment can start sooner.

This study looks at whether online psychotherapy, a physical activity program, or a combination of both can reduce fatigue in people with Post-COVID syndrome. About 195 adults with fatigue will take part in a 3-month program with online sessions every two weeks. The goal is to fi…

This study uses artificial intelligence to analyze data from 5,000 people with autoimmune hepatitis. The goal is to create computer models that can predict which patients will respond well to standard therapy within 6 to 12 months. By identifying these patterns early, doctors may…

This study involves 20 adults with chronic hepatitis delta who have been on bulevirtide treatment for at least 48 weeks. Researchers want to find biological markers (biomarkers) that can predict whether the virus will stay under control after stopping the drug. Participants stop …